Role of autophagy in Parkinson's disease

4Citations
Citations of this article
194Readers
Mendeley users who have this article in their library.

Abstract

Parkinson's disease (PD) is a neurodegenerative movement disorder featured by the degeneration of dopaminergic neurons within the substantia nigra. Although the etiology of sporadic disease still remains unclear, the identification of the gene products involved in hereditary variants has provided critical information about the molecular physiopathology of PD. Thus, it has been shown that morphologically this disorder is characterized by accumulation of misfolded protein aggregates and aberrant organelles in the neuronal structures and that these alterations can be triggered by different factors such as mitochondrial-induced oxidative stress and/or α-synuclein-mediated cytotoxicity. Recently, a growing line of evidence indicates that dysregulation of the two major autophagic pathways, macroautophagy and chaperone mediated autophagy, can be driving mechanisms of neurodegeneration. Aim of this chapter is to provide in-depth analysis of the experimental evidence connecting malfunction of autophagy with the PD pathogenesis. © 2012 by Nova Science Publishers, Inc. All rights reserved.

Cite

CITATION STYLE

APA

Stefanoni, G., Sala, G., Tremolizzo, L., Brighina, L., & Ferrarese, C. (2012). Role of autophagy in Parkinson’s disease. In Autophagy: Principles, Regulation and Roles in Disease (pp. 243–264). Nova Science Publishers, Inc. https://doi.org/10.2174/0929867325666180226094351

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free